COVID-19: Takeda Pharmaceutical, immunoglobulin clinical trial started: 500 participants from 18 countries
COVID-19: Chugai’s Actemra: Roche, 3P start in the world
Ivermectin Could Turn COVID-19 Around. We Need To Find Out If It Works.
COVID-19: Eisai to jointly develop therapeutic drug: Utilization of Eritoran and E6011
COVID-19: FUJIFILM signs contract with VLP Therapeutics: Vaccine manufacturing contract